Cancer-associated mutations in the guanosine triphosphatase (GTPase) RHOA are found at different locations from the mutational hotspots in the structurally and biochemically related RAS. Tyr
42
-to-Cys (Y42C) and Leu
57
-to-Val (L57V) substitutions are the two most prevalent RHOA mutations in diffuse gastric cancer (DGC). RHOA
Y42C
exhibits a gain-of-function phenotype and is an oncogenic driver in DGC. Here, we determined how RHOA
L57V
promotes DGC growth. In mouse gastric organoids with deletion of
Cdh1
, which encodes the cell adhesion protein E-cadherin, the expression of RHOA
L57V
, but not of wild-type RHOA, induced an abnormal morphology similar to that of patient-derived DGC organoids. RHOA
L57V
also exhibited a gain-of-function phenotype and promoted F-actin stress fiber formation and cell migration. RHOA
L57V
retained interaction with effectors but exhibited impaired RHOA-intrinsic and GAP-catalyzed GTP hydrolysis, which favored formation of the active GTP-bound state. Introduction of missense mutations at KRAS residues analogous to Tyr
42
and Leu
57
in RHOA did not activate KRAS oncogenic potential, indicating distinct functional effects in otherwise highly related GTPases. Both RHOA mutants stimulated the transcriptional co-activator YAP1 through actin dynamics to promote DGC progression; however, RHOA
L57V
additionally did so by activating the kinases IGF1R and PAK1, distinct from the FAK-mediated mechanism induced by RHOA
Y42C
. Our results reveal that RHOA
L57V
and RHOA
Y42C
drive the development of DGC through distinct biochemical and signaling mechanisms.